For the year ending 2025-12-31, CRNX has $1,126,257K in assets. $134,174K in debts. $101,536K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 101,536 | |||
| Restricted cash | 0 | |||
| Investment securities, amortized cost of 924,317 at december 31, 2025 and 1,088,561 at december 31, 2024 | 926,353 | |||
| Trade accounts receivable, net | 592 | |||
| Inventory | 2,022 | |||
| Prepaid expenses and other current assets | 17,839 | |||
| Total current assets | 1,048,342 | |||
| Property and equipment, net | 14,296 | |||
| Operating lease right-of-use assets | 40,492 | |||
| Restricted cash, net of current portion | 800 | |||
| Prepaid expenses and other assets, net of current portion | 22,327 | |||
| Total assets | 1,126,257 | |||
| Accounts payable and accrued expenses | 41,770 | |||
| Accrued compensation and related expenses | 35,578 | |||
| Deferred revenue | 1,235 | |||
| Operating lease liabilities | 6,489 | |||
| Total current liabilities | 85,072 | |||
| Operating lease liabilities, non-current | 42,052 | |||
| Deferred revenue, non-current | 3,810 | |||
| Other non-current liabilities | 3,240 | |||
| Total liabilities | 134,174 | |||
| Common stock and paid-in capital, 0.001 par 200,000 shares authorized, 92,926 shares issued and outstanding at december 31, 2025 68,175 shares issued and outstanding at december 31, 2024 | 2,407,757 | |||
| Accumulated other comprehensive income | 1,865 | |||
| Accumulated deficit | -1,417,427 | |||
| Stock held in trust | 112 | |||
| Total stockholders equity | 992,083 | |||
| Total liabilities and stockholders equity | 1,126,257 | |||
Crinetics Pharmaceuticals, Inc. (CRNX)
Crinetics Pharmaceuticals, Inc. (CRNX)